Literature DB >> 22764135

Accelerated elimination of ultraviolet-induced DNA damage through apoptosis in CDC25A-deficient skin.

Jodi Yanagida1, Brianna Hammiller, Jenan Al-Matouq, Michaela Behrens, Carol S Trempus, Susan K Repertinger, Laura A Hansen.   

Abstract

Cell division cycle 25A (CDC25A) is a dual-specificity phosphatase that removes inhibitory phosphates from cyclin-dependent kinases, allowing cell-cycle progression. Activation of cell-cycle checkpoints following DNA damage results in the degradation of CDC25A, leading to cell-cycle arrest. Ultraviolet (UV) irradiation, which causes most skin cancer, results in both DNA damage and CDC25A degradation. We hypothesized that ablation of CDC25A in the skin would increase cell-cycle arrest following UV irradiation, allowing for improved repair of DNA damage and decreased tumorigenesis. Cdc25a(fl/fl) /Krt14-Cre recombinase mice, with decreased CDC25A in the epithelium of the skin, were generated and exposed to UV. UV-induced DNA damage, in the form of cyclopyrimidine dimers and 8-oxo-deoxyguanosine adducts, was eliminated earlier from CDC25A-deficient epidermis. Surprisingly, loss of CDC25A did not alter epidermal proliferation or cell cycle after UV exposure. However, the UV-induced apoptotic response was prolonged in CDC25A-deficient skin. Double labeling of cleaved caspase-3 and the DNA damage marker γH2A.X revealed many of the apoptotic cells in UV-exposed Cdc25a mutant skin had high levels of DNA damage. Induction of skin tumors by UV irradiation of Cdc25a mutant and control mice on a skin tumor susceptible to v-ras(Ha) Tg.AC mouse background revealed UV-induced papillomas in Cdc25a mutants were significantly smaller than in controls in the first 6 weeks following UV exposure, although there was no difference in tumor multiplicity or incidence. Thus, deletion of Cdc25a increased apoptosis and accelerated the elimination of DNA damage following UV but did not substantially alter cell-cycle regulation or tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764135      PMCID: PMC3514895          DOI: 10.1093/carcin/bgs168

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

Review 2.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

Authors:  Aziz Sancar; Laura A Lindsey-Boltz; Keziban Unsal-Kaçmaz; Stuart Linn
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

3.  Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin.

Authors:  J G van der Schroeff; L M Evers; A J Boot; J L Bos
Journal:  J Invest Dermatol       Date:  1990-04       Impact factor: 8.551

4.  The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1.

Authors:  X Zou; T Tsutsui; D Ray; J F Blomquist; H Ichijo; D S Ucker; H Kiyokawa
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells.

Authors:  Y H You; D H Lee; J H Yoon; S Nakajima; A Yasui; G P Pfeifer
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

6.  Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor.

Authors:  Siddhartha Kar; Meifang Wang; Craig S Wilcox; Brian I Carr
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

7.  Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.

Authors:  M K Shigenaga; C J Gimeno; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Subcellular localisation of Cdc25A determines cell fate.

Authors:  C Leisser; G Rosenberger; S Maier; G Fuhrmann; M Grusch; S Strasser; S Huettenbrenner; S Fassl; D Polgar; S Krieger; C Cerni; R Hofer-Warbinek; R deMartin; G Krupitza
Journal:  Cell Death Differ       Date:  2004-01       Impact factor: 15.828

9.  Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletion.

Authors:  Gwanghee Lee; Lynn S White; Kristen E Hurov; Thaddeus S Stappenbeck; Helen Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

10.  Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei.

Authors:  L L Vindelov
Journal:  Virchows Arch B Cell Pathol       Date:  1977-08-10
View more
  4 in total

1.  Protective effect of tropical highland blackberry juice (Rubus adenotrichos Schltdl.) against UVB-mediated damage in human epidermal keratinocytes and in a reconstituted skin equivalent model.

Authors:  Laura Calvo-Castro; Deeba N Syed; Jean C Chamcheu; Fernanda M P Vilela; Ana M Pérez; Fabrice Vaillant; Miguel Rojas; Hasan Mukhtar
Journal:  Photochem Photobiol       Date:  2013-07-08       Impact factor: 3.421

2.  Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.

Authors:  Thomas Bertero; Isabelle Bourget-Ponzio; Alexandre Puissant; Agnès Loubat; Bernard Mari; Guerrino Meneguzzi; Patrick Auberger; Pascal Barbry; Gilles Ponzio; Roger Rezzonico
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

3.  A distinctive DNA methylation pattern in insufficient sleep.

Authors:  Alexandra Lahtinen; Sampsa Puttonen; Päivi Vanttola; Katriina Viitasalo; Sonja Sulkava; Natalia Pervjakova; Anni Joensuu; Perttu Salo; Auli Toivola; Mikko Härmä; Lili Milani; Markus Perola; Tiina Paunio
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

4.  A Method for the Immortalization of Newborn Mouse Skin Keratinocytes.

Authors:  Brianna O Hammiller; Taghrid Bahig El-Abaseri; Andrzej A Dlugosz; Laura A Hansen
Journal:  Front Oncol       Date:  2015-07-30       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.